中华预防医学杂志
中華預防醫學雜誌
중화예방의학잡지
CHINESE JOURNAL OF
2014年
11期
995-1000
,共6页
李其龙%俞玲玲%薛峰%马万里%姚开颜
李其龍%俞玲玲%薛峰%馬萬裏%姚開顏
리기룡%유령령%설봉%마만리%요개안
结直肠肿瘤%敏感性与特异性%优化序贯筛查
結直腸腫瘤%敏感性與特異性%優化序貫篩查
결직장종류%민감성여특이성%우화서관사사
Colorectal neoplasms%Sensitivity and specificity%Optimized sequential screening
目的:评价我国现行大肠癌优化序贯筛查方案的敏感度和特异度,为进一步优化我国现行大肠癌筛查方案提供依据。方法2011年5月至2013年11月先后从浙江省嘉善县4个项目点采用随机整群抽样法抽取4个行政村作为普查区,在普查区逐村招募年龄为40~74岁的研究对象,所有研究对象应用大肠癌优化序贯筛查方案进行初筛(包括问卷调查及粪便隐血试验),并同时完成结肠镜检查,分析检测结果,计算筛查方案的灵敏度和特异度。结果共2607名研究对象同时完成初筛和肠镜检查,共检出结直肠癌20例,进展期腺瘤85例,非进展期腺瘤271例,非腺瘤性息肉141例。优化序贯筛查方案对结直肠癌、进展期腺瘤、非进展期腺瘤的灵敏度分别为70畅0%(14/20)、57畅6%(49/85)、36畅5%(99/271),特异度分别为68畅7%(1776/2587)、69畅2%(1746/2522)、68畅9%(1610/2336);单独采用粪便隐血试验对结直肠癌、进展期腺瘤、非进展期腺瘤的灵敏度分别为70畅0%(14/20)、47畅1%(40/85)、26畅6%(72/271),特异度分别为79畅4%(2053/2587)、79畅9%(2014/2522)、79畅6%(1860/2336),与优化序贯筛查方案相比,结直肠癌、进展期腺瘤的灵敏度差异无统计学意义(χ2值分别为0畅00、1畅91,P值均>0畅05);单独采用问卷调查对结直肠癌、进展期腺瘤、非进展期腺瘤的灵敏度分别为10畅0%(2/20)、14畅1%(12/85)、12畅9%(35/271),特异度分别为87畅6%(2266/2587)、87畅7%(2211/2522)、87畅6%(2046/2336)。如果筛查方案去掉:慢性腹泻、慢性便秘、黏液便或血便史、慢性阑尾炎或阑尾手术史、慢性胆囊炎或胆囊手术史、不良生活事件史6个单项,对结直肠癌的灵敏度不变,进展期腺瘤、非进展期腺瘤的灵敏度下降较低,分别为70畅0%(14/20)、52畅9%(45/85)、31畅4%(85/271),差异无统计学意义(χ2=0畅38和1畅61,P值均>0畅05)。结论我国现行的大肠癌优化序贯筛查方案有较高的灵敏度和特异度,但有进一步优化的必要和空间。
目的:評價我國現行大腸癌優化序貫篩查方案的敏感度和特異度,為進一步優化我國現行大腸癌篩查方案提供依據。方法2011年5月至2013年11月先後從浙江省嘉善縣4箇項目點採用隨機整群抽樣法抽取4箇行政村作為普查區,在普查區逐村招募年齡為40~74歲的研究對象,所有研究對象應用大腸癌優化序貫篩查方案進行初篩(包括問捲調查及糞便隱血試驗),併同時完成結腸鏡檢查,分析檢測結果,計算篩查方案的靈敏度和特異度。結果共2607名研究對象同時完成初篩和腸鏡檢查,共檢齣結直腸癌20例,進展期腺瘤85例,非進展期腺瘤271例,非腺瘤性息肉141例。優化序貫篩查方案對結直腸癌、進展期腺瘤、非進展期腺瘤的靈敏度分彆為70暢0%(14/20)、57暢6%(49/85)、36暢5%(99/271),特異度分彆為68暢7%(1776/2587)、69暢2%(1746/2522)、68暢9%(1610/2336);單獨採用糞便隱血試驗對結直腸癌、進展期腺瘤、非進展期腺瘤的靈敏度分彆為70暢0%(14/20)、47暢1%(40/85)、26暢6%(72/271),特異度分彆為79暢4%(2053/2587)、79暢9%(2014/2522)、79暢6%(1860/2336),與優化序貫篩查方案相比,結直腸癌、進展期腺瘤的靈敏度差異無統計學意義(χ2值分彆為0暢00、1暢91,P值均>0暢05);單獨採用問捲調查對結直腸癌、進展期腺瘤、非進展期腺瘤的靈敏度分彆為10暢0%(2/20)、14暢1%(12/85)、12暢9%(35/271),特異度分彆為87暢6%(2266/2587)、87暢7%(2211/2522)、87暢6%(2046/2336)。如果篩查方案去掉:慢性腹瀉、慢性便祕、黏液便或血便史、慢性闌尾炎或闌尾手術史、慢性膽囊炎或膽囊手術史、不良生活事件史6箇單項,對結直腸癌的靈敏度不變,進展期腺瘤、非進展期腺瘤的靈敏度下降較低,分彆為70暢0%(14/20)、52暢9%(45/85)、31暢4%(85/271),差異無統計學意義(χ2=0暢38和1暢61,P值均>0暢05)。結論我國現行的大腸癌優化序貫篩查方案有較高的靈敏度和特異度,但有進一步優化的必要和空間。
목적:평개아국현행대장암우화서관사사방안적민감도화특이도,위진일보우화아국현행대장암사사방안제공의거。방법2011년5월지2013년11월선후종절강성가선현4개항목점채용수궤정군추양법추취4개행정촌작위보사구,재보사구축촌초모년령위40~74세적연구대상,소유연구대상응용대장암우화서관사사방안진행초사(포괄문권조사급분편은혈시험),병동시완성결장경검사,분석검측결과,계산사사방안적령민도화특이도。결과공2607명연구대상동시완성초사화장경검사,공검출결직장암20례,진전기선류85례,비진전기선류271례,비선류성식육141례。우화서관사사방안대결직장암、진전기선류、비진전기선류적령민도분별위70창0%(14/20)、57창6%(49/85)、36창5%(99/271),특이도분별위68창7%(1776/2587)、69창2%(1746/2522)、68창9%(1610/2336);단독채용분편은혈시험대결직장암、진전기선류、비진전기선류적령민도분별위70창0%(14/20)、47창1%(40/85)、26창6%(72/271),특이도분별위79창4%(2053/2587)、79창9%(2014/2522)、79창6%(1860/2336),여우화서관사사방안상비,결직장암、진전기선류적령민도차이무통계학의의(χ2치분별위0창00、1창91,P치균>0창05);단독채용문권조사대결직장암、진전기선류、비진전기선류적령민도분별위10창0%(2/20)、14창1%(12/85)、12창9%(35/271),특이도분별위87창6%(2266/2587)、87창7%(2211/2522)、87창6%(2046/2336)。여과사사방안거도:만성복사、만성편비、점액편혹혈편사、만성란미염혹란미수술사、만성담낭염혹담낭수술사、불량생활사건사6개단항,대결직장암적령민도불변,진전기선류、비진전기선류적령민도하강교저,분별위70창0%(14/20)、52창9%(45/85)、31창4%(85/271),차이무통계학의의(χ2=0창38화1창61,P치균>0창05)。결론아국현행적대장암우화서관사사방안유교고적령민도화특이도,단유진일보우화적필요화공간。
Objective To evaluate the sensitivity and specificity of optimized sequential screening program of colorectal cancer , and provide evidence for the further optimization of colorectal cancer screening program.Methods Using cluster sampling method , 4 administrative villages were selected from Jiashan county as a census district in 2011 to 2013.Volunteers of 40 to 74 years old in the census were recruited , and tested by both optimized sequential screening ( including questionnaire survey and fecal occult blood test ) and colonoscopy for colorectal cancer.Sensitivity and specificity of different screening methods were calculated, respectively.Results A total of 2 607 volunteers took both simultaneously screening and colonoscopy at the same time.20 colorectal cancer cases , 85 advanced adenoma cases , 271 non-advanced adenomas cases , and 141 non-adenomatous polyps cases were detected.Sensitivity of optimized sequential screening for colorectal cancer , advanced adenomas , and non-advanced adenomas were 70.0%( 14/20 ) , 57.6%(49/85) and 36.5%(99/271), specificity was 68.7%(1 776/2 587), 69.2%(1 746/2 522) and 68.9%(1 610/2 336), respectively.Sensitivity of the fecal occult blood test of colorectal cancer , advanced adenomas and non-advanced adenomas were 70.0%( 14/20 ) , 47.1%( 40/85 ) and 26.6%( 72/271 ) , specificity was 79.4%(2 053/2 587), 79.9%(2 014/2 522) and 79.6%(1 860/2 336).The sensitivity of fecal occult blood test and those of optimized sequential screening for colorectal cancer , advanced adenomas was not significent (χ2 =0.00,1.91,all P values >0.05).Sensitivity of questionnaire survey of colorectal cancer, advanced adenomas and non-advanced adenomas were 10.0%(2/20), 14.1%(12/85), 12.9%(35/271), specificity was 87.6%(2 266/2 587), 87.7%(2 211/2 522), 87.6%(2 046/2 336). There were no significant difference between non-advanced adenomas.The sensitivity of advanced adenomas and non-advanced adenomas showed no significant decline when the following six term were removed from screening programs: chronic diarrhea , chronic constipation , mucus or bloody history , history of chronic appendicitis or appendectomy surgery , chronic cholecystitis or gallbladder surgery , adverse events in the history of life, while the sensitivity of colorectal cancer remained nearly the same 70.0%(14/20),52.9%(45/85),31.4%( 85/271 ) (χ2 =0.38, 1.61, all P values >0.05 ).Conclusion Current optimized sequential screening programs for colorectal cancer in China have a high sensitivity and specificity .However , further optimization is viable and necessary.